Prahlad R.  Singh net worth and biography

Prahlad Singh Biography and Net Worth

Insider of Revvity
With more than 25 years of leadership experience working for global healthcare companies, Prahlad is professionally and personally motivated by the opportunity to make a positive impact on the world. Under his leadership, Revvity’s 11,000 employees deliver best-in-class solutions and service to a diverse range of organizations - advancing science that expands human health and improves lives worldwide.

Before his current role, Prahlad served as President and CEO of PerkinElmer, a position he was appointed to in 2019. During his time in this role, Prahlad led the company through a period of significant transformation - stewarding the organization through the COVID-19 pandemic and overseeing its dramatic portfolio evolution. He was also at the helm when the company completed the divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital, which resulted in the creation of Revvity. Prior to joining PerkinElmer in 2014, Prahlad was General Manager of GE Healthcare’s Women’s Health business. He has also held senior executive level roles in strategy, business development and mergers and acquisitions at both GE Healthcare and Philips Healthcare. Born and raised in India, Prahlad holds a bachelor’s degree in chemistry from the University of Bombay. He moved to the United States to continue his academic career at the University of Missouri-Columbia, where he earned a PhD in chemistry. Prahlad also holds an MBA from Northeastern University’s D’Amore-McKim School of Business. Prahlad currently serves on the Board of Directors of Amphenol Corporation and the Analytical, Life Science & Diagnostics Association (ALDA). Additionally, he is a member of the Massachusetts General Hospital President's Council and an honoree of the Ascend Foundation’s 2023 A-List Awards recognizing outstanding Pan-Asian leaders.

What is Prahlad R. Singh's net worth?

The estimated net worth of Prahlad R. Singh is at least $9.96 million as of February 5th, 2024. Dr. Singh owns 92,801 shares of Revvity stock worth more than $9,956,619 as of June 19th. This net worth evaluation does not reflect any other assets that Dr. Singh may own. Additionally, Dr. Singh receives an annual salary of $1,430,000.00 as Insider at Revvity. Learn More about Prahlad R. Singh's net worth.

How old is Prahlad R. Singh?

Dr. Singh is currently 59 years old. There are 5 older executives and no younger executives at Revvity. Learn More on Prahlad R. Singh's age.

What is Prahlad R. Singh's salary?

As the Insider of Revvity, Inc., Dr. Singh earns $1,430,000.00 per year. Learn More on Prahlad R. Singh's salary.

How do I contact Prahlad R. Singh?

The corporate mailing address for Dr. Singh and other Revvity executives is 940 WINTER STREET, WALTHAM MA, 02451. Revvity can also be reached via phone at (781) 663-6900 and via email at [email protected]. Learn More on Prahlad R. Singh's contact information.

Has Prahlad R. Singh been buying or selling shares of Revvity?

Prahlad R. Singh has not been actively trading shares of Revvity over the course of the past ninety days. Most recently, Prahlad R. Singh sold 21,217 shares of the business's stock in a transaction on Monday, February 5th. The shares were sold at an average price of $104.28, for a transaction totalling $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares of the company's stock, valued at $9,677,288.28. Learn More on Prahlad R. Singh's trading history.

Are insiders buying or selling shares of Revvity?

In the last year, insiders at the sold shares 2 times. They sold a total of 25,217 shares worth more than $2,654,348.76. The most recent insider tranaction occured on June, 7th when insider Joel S Goldberg sold 4,000 shares worth more than $441,840.00. Insiders at Revvity own 0.6% of the company. Learn More about insider trades at Revvity.

Information on this page was last updated on 6/7/2024.

Prahlad R. Singh Insider Trading History at Revvity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/5/2024Sell21,217$104.28$2,212,508.7692,801View SEC Filing Icon  
See Full Table

Prahlad R. Singh Buying and Selling Activity at Revvity

This chart shows Prahlad R Singh's buying and selling at Revvity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Revvity Company Overview

Revvity logo
Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $107.29
Low: $106.55
High: $108.38

50 Day Range

MA: $106.63
Low: $99.33
High: $113.27

2 Week Range

Now: $107.29
Low: $79.50
High: $131.96

Volume

583,157 shs

Average Volume

954,018 shs

Market Capitalization

$13.24 billion

P/E Ratio

88.67

Dividend Yield

0.26%

Beta

1.08